Objective-To compare the visualisation of bronchopulmonary collaterals and bronchopulmonary collateral blood flow in patients with chronic thromboembolic pulmonary hypertension and primary pulmonary hypertension.
The recognition of chronic thromboembolic obstruction of the central, lobar, and segmental pulmonary arteries resulting in pulmonary hypertension is important since this is potentially curable by pulmonary thromboendarterectomy.' On the other hand, the management of the majority of patients with primary pulmonary hypertension continues to be disappointing despite advances in pharmacotherapy and transplantation.2-5 At present, the differentiation of chronic thromboembolic pulmonary hypertension from primary pulmonary hypertension depends mainly on the perfusion-ventilation lung scan and pulmonary angiography. 2 6 7 The risk of pulmonary angiography in patients with severe pulmonary hypertension and the precautions during angiography need special emphasis.1 7 More recently high resolution computerised tomography,8 magnetic resonance imaging,8 pulmonary intravascular imaging,9 and transoesophageal echocardiography'0 have been used for the detection of pulmonary thrombi. The separation of thromboembolic pulmonary hypertension from primary pulmonary hypertension is at times difficult, and made more so by the development of in situ thrombosis of the pulmonary arteries in patients with primary pulmonary hypertension." Many chronic and acute lung diseases are associated with an increase in bronchopulmonary collaterals and bronchial arterial blood flow.'2-'4 Extensive bronchopulmonary collaterals develop to parts of the lung affected by ligation of the pulmonary artery or its branches,'516 and after experimental pulmonary embolisation. 17 In patients with pulmonary embolism, bronchopulmonary collaterals to the affected segments have been demonstrated at necropsy'8 and during life.'9-2' This report is based on our observations of bronchopulmonary collaterals and bronchopulmonary collateral blood flow in patients with chronic thromboembolic pulmonary hypertension and primary pulmonary hypertension. This study was not designed to compare the different methods for detecting pulmonary thromboembolism.
Methods

PATIENT GROUPS
We studied nine patients with severe thromboembolic pulmonary hypertension and 17 with primary pulmonary hypertension. Haemodynamic criteria for inclusion in the thromboembolic group were pulmonary arterial systolic pressure of > 70 mm Hg; pulmonary arterial mean pressure of > 45 mm Hg; and pulmonary vascular resistance index of > 10 units. After a full clinical assessment, the diagnosis was based on the results of perfusion-ventilation lung scans and pulmonary angiography using previously described criteria. 1 Dye curves were recorded using BD5 or BD9 recorders (Kipp and Zonen, Delft, The Netherlands) using a D-402A densitometer (Waters Instruments, Rochester, Minnesota, USA) with the measuring cuvette directly connected to the catheter to reduce the sampling volume. All dye dilution curves were recorded at least twice. A constant rate of blood withdrawal through the cuvette was achieved using a Harvard pump at 40 ml/min speed (Harvard Apparatus, Southnatick, Massachusetts, USA). Blood was infused back to the patient after each recording. Early on, the curve areas were measured by planimetry,26 and in later studies using the Hewlett-Packard catheterisation computer adapted by one of us JE) for on line measurement of shunts. An example of the dye curves recorded is shown in fig 1. The first dye curve (B) measured the pulmonary blood flow by injection of indocyanine green (usually 5 mg) into the pulmonary artery, with sampling from the aorta. The second curve (C) was recorded by injection of double or quadruple amount of dye into the ascending aorta and sampling just below the mitral valve through a transseptal or retrograde catheter, to detect any aorto-pulmonary shunt. In the presence of bronchopulmonary collateral flow, the early recirculation had an appearance time of about three seconds, while the normal recirculation usually started after 10 seconds. The bronchopulmonary collateral flow was calculated as the ratio of the shunt curve area (C) divided by the pulmonary blood flow area (B). This value multiplied by the pulmonary blood flow gives the bronchopulmonary collateral flow in litres per minute. The systemic blood flow (SBF) was derived by subtracting the bronchopulmonary collateral flow (BPCF) from the pulmonary blood flow.
Then, BF x 100 = BPCF as % of SBF SBF boembolic pulmonary hypertension and all showed bronchopulmonary collaterals. Aortography was performed in three patients with thromboembolic pulmonary hypertension and this also showed bronchopulmonary collaterals ( fig 5) . Aortography ( fig 6) was done in five patients with primary pulmonary hypertension and bronchopulmonary collaterals were not seen.
Discussion
Thromboembolic pulmonary vascular disease embraces many syndromes, depending on the segments of the pulmonary arterial tree that are primarily affected.2728 Occlusion of the small muscular arteries and arterioles, which was in the past referred to as microthromboembolism, is now attributed to organised thrombi rather than emboli. 28 In chronic thromboembolic pulmonary hypertension the obstruction is in the larger proximal and intermediate pulmonary arteries. This type of thromboembolic obstruction can be treated by pulmonary thromboendarterectomy.' Generally by the time the diagnosis is made the clots become organised into the vessel wall, and interpretation of the pulmonary angiogram can be difficult.' 7 The medial hypertrophy of pulmonary arteries in thromboembolic pulmonary hypertension is often mild or absent, suggesting that vasoconstriction does not play an important role.27 In proximal thromboembolic pulmonary hypertension the smaller pulmonary arteries and arterioles are generally unaffected, allowing a pressure gradient between the potential bronchopulmonary anastomoses. There is also an initial injury to the lung parenchyma from pulmonary infarction. On the other hand, in primary pulmonary hypertension the predominant vascular lesions are in the small muscular arteries and arterioles. 29 The changes are bilateral, widespread, uniform, and not confined to a particular segment of the lung.29 30 At necropsy in primary pulmonary hypertension there is no embolic source and in one study thromboembolic lesions were present in less than 3% of small pulmonary arteries.30 Fibrinoid necrosis and plexiform lesions, believed to be related to intense vasoconstriction, are regularly observed in advanced stages. 2 The bronchial arteries, usually two major arteries to each lung arise from the thoracic aorta or an intercostal artery. The right bronchial arteries usually arise from the intercostal arteries, generally the first intercostal. The left bronchial arteries commonly arise directly from the aorta. Rarely the bronchial arteries originate from the internal mammary or coronary arteries and can therefore be missed on aortography.'4 At the level of the respiratory bronchioles, the bronchial arteries
VISUALISATION OF BRONCHOPULMONARY COLLATERALS
Selective bronchial arteriography (fig 4) was done in seven of the nine patients with thromgive rise to capillaries which communicate with pulmonary capillaries.29 The bronchial veins from the extrapulmonary airway finally drain into the right heart. The bronchial veins from the intrapulmonary airways and lung parenchyma drain through the "bronchopul-monary collateral" flow into the left atrium.'4 Thus sampling from the left ventricle below the mitral valve would detect bronchopulmonary collateral flow. The bronchial arterial blood flow in the human lung is of the order of 1-2% of the cardiac output.29 Many chronic and acute lung diseases are associated with an increase in bronchial blood flow. This has been shown for bronchiectasis and granulomas, pulmonary interstitial fibrosis, bronchogenic carcinoma, pleural disease, asthma, bronchitis, emphysema, and acute conditions like pneumonia and adult respiratory disease syndrome. 14 Ligation of a pulmonary artery in the dog results in the development of bronchopulmonary collaterals to the affected side, and the collateral blood flow could be as much as one third of the output of the right ventricle.'5 Malik and Tracy'7 used beads to embolise the pulmonary circulation to a degree sufficient to increase the pulmonary artery pressure and pulmonary vascular resistance to about three times the normal value. They observed that the bronchial blood flow did not change at five minutes, decreased at six minutes, and was greatly increased to around 300% at two weeks postembolisation.'7 Orell and Hultgren'8 carried out postmortem bronchial arteriography in 28 cases with pulmonary thromboemboli of varying ages. In 18 of the 23 cases with emboli more than two weeks old, there was filling of the pulmonary artery distal to the occlusions through bronchopulmonary collaterals. In this study, bronchopulmonary arterial anastomoses at the level of 1-2 mm thick peripheral bronchi were the most common. Matsuda21 performed bronchial arteriography in 23 patients with documented pulmonary embolism. All 17 patients in the chronic stage with no radiological infiltrates had bronchial to pulmonary arterial collaterals with antegrade filling of the distal pulmonary arteries. By contrast only one out of six had such collateral vessels when studied at a time when radiological infiltrates were still present.
Injection of indocyanine green in the ascending aorta and sampling below the mitral valve will detect an aortopulmonary shunt. None of our patients had a patent arterial duct. Significant bronchopulmonary collateral flow was present in all eight of our patients with thromboembolic pulmonary hypertension in whom the assessment was made. On the other hand there was no detectable bronchopulmonary collateral flow in 11 of 15 patients with primary pulmonary hypertension. In the remaining four patients the flow was small. The difference in bronchopulmonary collateral flow between thromboembolic pulmonary hypertension and primary pulmonary hypertension patients was highly significant (fig 3) . The cardiac and pulmonary vascular indices were comparable in the thromboembolic and primary pulmonary hypertension patients.
Normal bronchial arteries may be visualised on routine cineangiography when contrast material is injected into the descending thoracic aorta, but bronchopulmonary communications are not seen. In our study, selective bronchial arteriography or aortography showed that all patients with thromboembolic pulmonary hypertension had dilated bronchial arteries and a mesh of bronchopulmonary collaterals. The bronchopulmonary collaterals were seen to fill the pulmonary arterial branches downstream of the site of embolic occlusion. Aortography did not show dilated bronchial arteries or bronchopulmonary collaterals in any of the patients with primary pulmonary hypertension. Selective bronchial arteriography was not performed in patients with primary pulmonary hypertension as they had either undetectable or minimal bronchopulmonary collateral flow. Pulmonary hypertension per se is clearly not the stimulus for the development of bronchopulmonary collaterals in thromboembolic pulmonary hypertension since the increase in pulmonary artery pressure was equally severe in primary pulmonary hypertension. The development of bronchopulmonary collaterals in several acute and chronic lung conditions suggests that an initial stimulus may be damage to the lung tissue, and such damage is not a feature of primary pulmonary hypertension. Experimental and clinical observations show that the development of bronchopulmonary collaterals takes about 10-14 days after the embolic episode and the collaterals increase with time.'7 1821 The short time taken for the collateral development suggests that any difference in the length of survival of patients with thromboembolic versus primary pulmonary hypertension is unimportant. The obstructive pulmonary artery lesions with thromboembolic pulmonary hypertension are patchy and largely spare the small pulmonary arteries and arterioles.27 This would allow a pressure flow gradient to develop between the systemic bronchial circulation and the pulmonary circulation distal to the block in the proximal pulmonary arteries, thus encouraging the development of bronchopulmonary collaterals.
CONCLUSIONS
Large bronchopulmonary collaterals and an increase in collateral flow were found in patients with thromboembolic pulmonary hypertension and not in primary pulmonary hypertension. These bronchopulmonary collaterals can be demonstrated on thoracic aortography without resorting to selective bronchial arteriography or an estimation of collateral blood flow.
This study helps in our understanding of some of the pathophysiological differences between thromboembolic pulmonary hypertension and primary pulmonary hypertension. The use to which this observation is put could depend upon the clinical situation. In the context of thromboembolic and primary pulmonary hypertension, the demonstration of bronchopulmonary collaterals establishes the presence of proximal pulmonary thromboembolism. At present, pulmonary angiography may be considered essential while planning pulmonary thromboendarterectomy. The
